Elex Biotech Awarded NIH Small Business Grant to Develop Drugs to Treat Heart Arrhythmias
Tuesday, November 11, 2014 - 7:50am
Portland, Oregon, November 7, 2014 — Elex Biotech, LLC, a biotech firm with ties to Portland State University (PSU), has received a two-year grant for over $1.4 Million from the National Institutes of Health. The grant will help support development of new drug compounds for the treatment of heart arrhythmias in catecholaminergic polymorphic ventricular tachycardia (CPVT), an often-fatal inherited disorder.
New faculty member Steve Reichow studies the form and function of membrane proteins, a class of proteins with potentially significant implications for our understanding of physiology and the targeted treatment of disease.
Jonathan Fink, Vice President of Research & Strategic Partnerships, travels to Rwanda to meet PSU Professor Evan Thomas who is in the country working on a program to reduce childhood diarrhea and pneumonia.
Julie Rutherford, Maseeh College of Engineering and Computer Science
Wednesday, September 24, 2014 - 10:02am
Students from Portland State University (PSU) joined the nation’s top semiconductor scholars and industry leaders to share their research at the Semiconductor Research Corporation’s (SRC) 16th annual TECHCON conference held Sept. 7-9 in Austin, Texas.